HDAC2 and colorectal carcinoma: The selective HDAC2 inhibitor similarly recapitulated the influences of butyrate on CRC organoids.<h4>Discussion</h4>Butyrate exerts the definitive blocking effects on cell cycle progression in CRC organoids, and HDAC2 is one of the important targets.